Here, using a recently described mouse model of dilated cardiomyopathy with impaired NAD+ metabolism due to a dysfunctional cardiac circadian clock (lack of REV-ERB nuclear receptors), we show that treatment with the NAD+ precursor, NR, improves cardiac function and mortality. This evidence concerns the gene CLOCK and dilated cardiomyopathy.